Sinopharm Becomes China’s First RMB 100 Billion Drug Giant
This article was originally published in PharmAsia News
Executive Summary
Sinopharm’s 2011 revenues topped RMB 110 billion, making it the country’s first drug giant to have exceeded RMB 100 billion in sales, according to China’s Ministry of Commerce.